SPAG5 and ovarian cancer: The IHC assay showed that ovarian cancer tissues from 56 of 102 cases exhibited high SPAG5 expression and that paracancerous tissues from 42 cases had high SPAG5 expression; the difference was significant (P < 0.001, Figure 2C).